Literature DB >> 20074824

Establishment of a radiogenomics consortium.

Catharine West, Barry S Rosenstein.   

Abstract

Mesh：

Year:  2010        PMID： 20074824     DOI： 10.1016/j.radonc.2009.12.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  20 in total

1.  Predicting toxicity from radiation therapy--it's genetic, right?

Authors:  Chris R Kelsey; Barry S Rosenstein; Lawrence B Marks
Journal:  Cancer       Date:  2011-12-05       Impact factor: 6.860

2.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

3.  Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Authors:  Lindsay M Morton; Luisel Ricks-Santi; Catharine M L West; Barry S Rosenstein
Journal:  Int J Part Ther       Date:  2018-09-21

Review 4.  Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.

Authors:  Sarah L Kerns; Harry Ostrer; Barry S Rosenstein
Journal:  Cancer Discov       Date:  2014-01-17       Impact factor: 39.397

5.  HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.

Authors:  Ting Xu; Qingyi Wei; Jose Luis Lopez Guerra; Li-E Wang; Zhensheng Liu; Daniel Gomez; Michael O'Reilly; Steven Hsesheng Lin; Yan Zhuang; Lawrence B Levy; Radhe Mohan; Honghao Zhou; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-19       Impact factor: 7.038

6.  Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Aaron J Grossberg; Xiudong Lei; Ting Xu; Simona F Shaitelman; Karen E Hoffman; Elizabeth S Bloom; Michael C Stauder; Welela Tereffe; Pamela J Schlembach; Wendy A Woodward; Thomas A Buchholz; Benjamin D Smith
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

7.  A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.

Authors:  Anusha Kalbasi; Mitchell Kamrava; Fang-I Chu; Donatello Telesca; Ritchell Van Dams; Yingli Yang; Dan Ruan; Scott D Nelson; Sarah M Dry; Jackie Hernandez; Bartosz Chmielowski; Arun S Singh; Susan V Bukata; Nicholas M Bernthal; Michael L Steinberg; Joanne B Weidhaas; Fritz C Eilber
Journal:  Clin Cancer Res       Date:  2020-02-13       Impact factor: 12.531

Review 8.  Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.

Authors:  Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

Review 9.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

Review 10.  Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors:  K E Applegate; W Rühm; A Wojcik; M Bourguignon; A Brenner; K Hamasaki; T Imai; M Imaizumi; T Imaoka; S Kakinuma; T Kamada; N Nishimura; N Okonogi; K Ozasa; C E Rübe; A Sadakane; R Sakata; Y Shimada; K Yoshida; S Bouffler
Journal:  Radiat Environ Biophys       Date:  2020-03-07       Impact factor: 1.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.